These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 24491811)

  • 1. Cellular interplay in pulmonary arterial hypertension: implications for new therapies.
    Nogueira-Ferreira R; Ferreira R; Henriques-Coelho T
    Biochim Biophys Acta; 2014 May; 1843(5):885-93. PubMed ID: 24491811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and molecular pathobiology of pulmonary arterial hypertension.
    Humbert M; Morrell NW; Archer SL; Stenmark KR; MacLean MR; Lang IM; Christman BW; Weir EK; Eickelberg O; Voelkel NF; Rabinovitch M
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):13S-24S. PubMed ID: 15194174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension.
    Humbert M; Montani D; Perros F; Dorfmüller P; Adnot S; Eddahibi S
    Vascul Pharmacol; 2008; 49(4-6):113-8. PubMed ID: 18606248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension.
    Perros F; Ranchoux B; Izikki M; Bentebbal S; Happé C; Antigny F; Jourdon P; Dorfmüller P; Lecerf F; Fadel E; Simonneau G; Humbert M; Bogaard HJ; Eddahibi S
    J Am Coll Cardiol; 2015 Feb; 65(7):668-80. PubMed ID: 25677428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication.
    Guignabert C; Tu L; Girerd B; Ricard N; Huertas A; Montani D; Humbert M
    Chest; 2015 Feb; 147(2):529-537. PubMed ID: 25644906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of platelets in the development and progression of pulmonary arterial hypertension.
    Kazimierczyk R; Kamiński K
    Adv Med Sci; 2018 Sep; 63(2):312-316. PubMed ID: 29885631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin signalling system as a target for pulmonary arterial hypertension therapy.
    Huertas A; Tu L; Thuillet R; Le Hiress M; Phan C; Ricard N; Nadaud S; Fadel E; Humbert M; Guignabert C
    Eur Respir J; 2015 Apr; 45(4):1066-80. PubMed ID: 25745038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal Mechanisms of Vascular Remodeling in the Development of Pulmonary Arterial Hypertension.
    Li MX; Jiang DQ; Wang Y; Chen QZ; Ma YJ; Yu SS; Wang Y
    J Cardiovasc Pharmacol; 2016 Feb; 67(2):182-90. PubMed ID: 26448276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The etiopathogenesis of pulmonary hypertension: inflammation, vascular remodeling].
    Kayikçioğlu M
    Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():5-8. PubMed ID: 20819761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular remodeling in pulmonary arterial hypertension: multiple cancer-like pathways and possible treatment modalities.
    Sakao S; Tatsumi K
    Int J Cardiol; 2011 Feb; 147(1):4-12. PubMed ID: 20692712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.
    Antigny F; Hautefort A; Meloche J; Belacel-Ouari M; Manoury B; Rucker-Martin C; Péchoux C; Potus F; Nadeau V; Tremblay E; Ruffenach G; Bourgeois A; Dorfmüller P; Breuils-Bonnet S; Fadel E; Ranchoux B; Jourdon P; Girerd B; Montani D; Provencher S; Bonnet S; Simonneau G; Humbert M; Perros F
    Circulation; 2016 Apr; 133(14):1371-85. PubMed ID: 26912814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current insights on the pathogenesis of pulmonary arterial hypertension.
    Perros F; Dorfmüller P; Humbert M
    Semin Respir Crit Care Med; 2005 Aug; 26(4):355-64. PubMed ID: 16121311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of pulmonary hypertension.
    Yildiz P
    Clin Chim Acta; 2009 May; 403(1-2):9-16. PubMed ID: 19361468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric pulmonary arterial hypertension: current and emerging therapeutic options.
    Oishi P; Datar SA; Fineman JR
    Expert Opin Pharmacother; 2011 Aug; 12(12):1845-64. PubMed ID: 21609302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crucial role of ROCK2 in vascular smooth muscle cells for hypoxia-induced pulmonary hypertension in mice.
    Shimizu T; Fukumoto Y; Tanaka S; Satoh K; Ikeda S; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2780-91. PubMed ID: 24135024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
    Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
    Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle-like cells in pulmonary hypertension.
    Ricard N; Tu L; Le Hiress M; Huertas A; Phan C; Thuillet R; Sattler C; Fadel E; Seferian A; Montani D; Dorfmüller P; Humbert M; Guignabert C
    Circulation; 2014 Apr; 129(15):1586-97. PubMed ID: 24481949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted therapies in pulmonary arterial hypertension.
    Montani D; Chaumais MC; Guignabert C; Günther S; Girerd B; Jaïs X; Algalarrondo V; Price LC; Savale L; Sitbon O; Simonneau G; Humbert M
    Pharmacol Ther; 2014 Feb; 141(2):172-91. PubMed ID: 24134901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the monocrotaline animal model for the study of pulmonary arterial hypertension: A network approach.
    Nogueira-Ferreira R; Vitorino R; Ferreira R; Henriques-Coelho T
    Pulm Pharmacol Ther; 2015 Dec; 35():8-16. PubMed ID: 26403584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin knockout attenuates hypoxia-induced pulmonary arterial hypertension by inhibiting proliferation of pulmonary arterial smooth muscle cells.
    Chai S; Wang W; Liu J; Guo H; Zhang Z; Wang C; Wang J
    Transl Res; 2015 Dec; 166(6):772-82. PubMed ID: 26470682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.